HER-2 Tissue Expression Correlated with Serum Levels in Breast Cancer Patients
Olga Přibylová1, D. Springer2, I. Vítková3, T. Zima2, L. Petruželka1
1Department of Oncology, Charles University in Prague, 1st Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic 2Institute of Clinical Biochemistry, Charles University in Prague, 1st Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic 3Department of Clinical Pathology, Charles University in Prague, 1st Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic
Received April 2007
Accepted May 2007
Crossref Cited-by Linking
Leyland-Jones Brian, Smith Brian R: Serum HER2 testing in patients with HER2-positive breast cancer: the death knell tolls. The Lancet Oncology2011, 12, 286. <https://doi.org/10.1016/S1470-2045(10)70297-7>